Metropolitan Life Insurance CO Horizon Therapeutics Public LTD CO Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jun 21, 2023	BUY	$98.56 - $119.91 $616,591 - $750,156	6,256 New	6,256 $674 Million
Q3 2021 Jun 21, 2023	BUY	$91.91 - $110.37 $575,999 - $691,688	6,267 New	6,267 $686 Million
Q1 2021 Jun 26, 2023	BUY	$71.83 - $95.48 $963,958 - $1.28 Million	13,420 New	13,420 $1.24 Billion
Q4 2020 Jun 22, 2023	BUY	$67.0 - $84.39 $938,000 - $1.18 Million	14,000 New	14,000 $1.02 Billion
Q3 2020 Jun 26, 2023	BUY	$55.23 - $79.93 $788,408 - $1.14 Million	14,275 New	14,275 $1.11 Billion
Q2 2020 Jun 26, 2023	BUY	$30.2 - $56.98 $416,427 - $785,697	13,789 New	13,789 $766 Million
Q1 2020 Jul 12, 2023	BUY	$24.87 - $38.56 $136,486 - $211,617	5,488 New	5,488 $163 Million
Q4 2019 Jul 12, 2023	BUY	$25.43 - $36.67 $140,780 - $203,005	5,536 New	5,536 $200 Million
Q3 2019 Jul 12, 2023	BUY	$23.0 - $27.97 $126,040 - $153,275	5,480 New	5,480 $149 Million
Q2 2019 Jul 12, 2023	BUY	$22.81 - $28.48 $1.29 Million - $1.61 Million	56,705 New	56,705 $1.36 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.